The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
Abstract Background Disseminated intravascular coagulation (DIC) is a common and critical complication in sepsis. Antithrombin activity, which is considered a biomarker for disease severity, was measured in septic DIC treated with antithrombin concentrates in this study. Methods We conducted a retro...
Main Authors: | Toshiaki Iba, Tomoki Tanigawa, Hideo Wada, Jerrold H. Levy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-023-00556-6 |
Similar Items
-
Determining prognostic indicator for anticoagulant therapy in sepsis-induced disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2024-06-01) -
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis
by: Takaaki Totoki, et al.
Published: (2024-01-01) -
Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2017-11-01) -
Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute Cholangitis
Published: (2013-05-01) -
The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2023-05-01)